Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Hyperphosphataemia
Age: Adult
Condition: Chronic renal failure
Dose: Chewable tablet or oral powder – Initially, 0.75-2.25 g
Frequency: in 3 divided doses daily
Note: Initial dose
Indication: Hyperphosphataemia
Age: Adult
Condition: Chronic renal failure
Dose: Chewable tablet or oral powder – 1.5-3 g
Frequency: in divided doses daily
Note: Maintenance dose

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: No approved pediatric dosage available
Note: No approved pediatric dosage available
Administration
  • Take with or immediately after meals
  • Chew tablets completely
Side Effect

Drug Interaction

Drug NameRisk Factors
Quinolones, tetracycline, levothyroxine, chloroquine, ketoconazole
May reduce bioavailability
ACE Inhibitors (Captopril, Enalapril, Lisinopril, Ramipril, Benazepril, Fosinopril, Quinapril, Perindopril), ampicillin, halofantrine
May decrease serum concentration

Disease Interaction

Disease NameRisk Factors
Bowel Obstruction, Ileus
Risk of intestinal complications
Faecal Impaction
Risk of severe constipation

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool (below 30° C) and dry place, away from light. Keep out of the reach of children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.